Skip to main content

Aspera Faspex

28 CVEs product

Monthly

CVE-2025-36227 Mar 10, 20:16 MEDIUM This Month

Aspera Faspex versions up to 5.0.14.3 contains a vulnerability that allows attackers to conduct various attacks against the vulnerable system, including cross-site scri (CVSS 5.4).

XSS IBM Aspera Faspex
NVD VulDB
CVSS 3.1
5.4
EPSS
0.0%
CVE-2025-36226 Mar 10, 20:16 MEDIUM This Month

IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. [CVSS 5.4 MEDIUM]

XSS IBM Aspera Faspex
NVD VulDB
CVSS 3.1
5.4
EPSS
0.0%
CVE-2025-36230 Dec 26, 15:15 MEDIUM This Month

HTML injection in IBM Aspera Faspex 5 (versions 5.0.0 through 5.0.14.1) allows an authenticated, low-privileged user to plant attacker-controlled HTML that is later rendered in a second victim's browser within the security context of the Faspex site. The triggering user must hold a valid Faspex account and must persuade or induce another user to view the affected content, and the impact stays confined to that victim's browsing session on the Faspex origin rather than the server itself. No public exploit code has been identified at time of analysis and there is no confirmed active exploitation (CISA KEV); with a CVSS 3.1 base score of 5.4, this is a moderate-severity, social-engineering-dependent issue rather than a mass-exploitation emergency.

XSS IBM Aspera Faspex
NVD VulDB
CVSS 3.1
5.4
EPSS
0.2%
CVE-2025-36229 Dec 26, 15:15 MEDIUM This Month

Authenticated users of IBM Aspera Faspex 5 (versions 5.0.0 through 5.0.14.1) can enumerate package identifiers to expose sensitive information about data packages they should not have visibility into. The flaw requires a valid low-privilege Faspex account and network access to the web application or API (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N, score 4.3), so it is not exploitable without credentials and impact is limited to confidentiality - no integrity or availability effect. With no public exploit identified at time of analysis and no confirmed active exploitation (not in CISA KEV), this is a low-to-moderate priority issue best addressed by upgrading and tightening package-level authorization, with risk scaling on multi-tenant instances that host many users' packages.

Information Disclosure IBM Aspera Faspex
NVD VulDB
CVSS 3.1
4.3
EPSS
0.2%
CVE-2025-36228 Dec 26, 15:15 LOW Monitor

Authenticated users of IBM Aspera Faspex 5 can access backend API features that are disabled in the web interface due to inconsistent permission enforcement (CWE-279), potentially leading to misuse of those features. Affected versions are 5.0.0 through 5.0.14.1. Exploitation requires a valid session and does not involve user interaction; impact is limited to low confidentiality and integrity effects, and no public exploit or active exploitation has been identified. This is assessed as a low-severity, low-priority access-control weakness.

Information Disclosure IBM Aspera Faspex
NVD VulDB
CVSS 3.1
3.8
EPSS
0.2%
CVE-2025-36225 Oct 09, 14:15 MEDIUM This Month

IBM Aspera Faspex versions 5.0.0 through 5.0.13.1 allow an authenticated low-privilege user to infer sensitive system information by observing discrepancies in returned data (CWE-203). The vulnerability requires valid credentials and only affects confidentiality with limited impact, as no data modification or service disruption is possible. No public exploit code has been identified, and the EPSS score is 0.23%, indicating a low likelihood of exploitation.

Information Disclosure IBM Aspera Faspex
NVD
CVSS 3.1
4.3
EPSS
0.2%
CVE-2025-36171 Oct 09, 14:15 MEDIUM This Month

Denial of service in IBM Aspera Faspex 5.0.0 through 5.0.13.1 allows a high-privileged, authenticated API user to consume excessive resources through improperly validated input, causing availability loss. Because exploitation requires PR:H credentials, realistic risk is confined to malicious insiders or post-compromise scenarios; EPSS is 0.32% (23rd percentile) and no public exploit has been identified at time of analysis.

Denial Of Service IBM Aspera Faspex
NVD
CVSS 3.1
4.9
EPSS
0.3%
CVE-2025-33138 May 22, 17:15 MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.12 is vulnerable to HTML injection. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

XSS IBM Aspera Faspex
NVD
CVSS 3.1
5.4
EPSS
0.1%
CVE-2025-33137 May 22, 17:15 HIGH This Week

IBM Aspera Faspex 5.0.0 through 5.0.12 could allow an authenticated user to obtain sensitive information or perform unauthorized actions on behalf of another user due to client-side enforcement of. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Information Disclosure IBM Aspera Faspex
NVD
CVSS 3.1
7.1
EPSS
0.2%
CVE-2025-33136 May 22, 17:15 HIGH This Week

IBM Aspera Faspex 5.0.0 through 5.0.12 could allow an authenticated user to obtain sensitive information or perform unauthorized actions on behalf of another user due to improper protection of. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Information Disclosure IBM Aspera Faspex
NVD
CVSS 3.1
7.1
EPSS
0.2%
CVE-2025-3423 Apr 13, 12:15 MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

XSS IBM Aspera Faspex
NVD
CVSS 3.1
5.4
EPSS
0.1%
CVE-2023-37413 Jan 29, 17:15 MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.10 could disclose sensitive username information due to an observable response discrepancy. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Information Disclosure IBM Aspera Faspex
NVD
CVSS 3.1
5.3
EPSS
0.2%
CVE-2023-37412 Jan 29, 17:15 MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.10 could allow a privileged user to make system changes without proper access controls. Rated medium severity (CVSS 4.4), this vulnerability is remotely exploitable. No vendor patch available.

Privilege Escalation IBM Aspera Faspex
NVD
CVSS 3.1
4.4
EPSS
0.1%
CVE-2023-37398 Jan 29, 17:15 MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.10 does not require that users should have strong passwords by default, which makes it easier for attackers to compromise user accounts. Rated medium severity (CVSS 5.9), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure IBM Brute Force Aspera Faspex
NVD
CVSS 3.1
5.9
EPSS
0.2%
CVE-2023-35907 Jan 29, 17:15 MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.10 does not require that users should have strong passwords by default, which makes it easier for attackers to compromise user accounts. Rated medium severity (CVSS 5.9), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure IBM Brute Force Aspera Faspex
NVD
CVSS 3.1
5.9
EPSS
0.2%
CVE-2024-45098 Sep 05, 16:15 HIGH This Week

IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user to bypass intended access restrictions and conduct resource modification. Rated high severity (CVSS 8.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass IBM Aspera Faspex
NVD
CVSS 3.1
8.1
EPSS
0.4%
CVE-2024-45097 Sep 05, 16:15 HIGH This Week

IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user to bypass intended access restrictions and conduct resource modification. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass IBM Aspera Faspex
NVD
CVSS 3.1
7.1
EPSS
0.3%
CVE-2024-45096 Sep 05, 16:15 MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user with access to the package to obtain sensitive information through a directory listing. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Information Disclosure IBM Aspera Faspex
NVD
CVSS 3.1
6.5
EPSS
0.4%
CVE-2023-30995 Sep 08, 21:15 HIGH PATCH This Week

IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist restrictions using a specially crafted HTTP request. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. This Incorrect Authorization vulnerability could allow attackers to bypass authorization checks to access restricted resources.

Authentication Bypass IBM Aspera Faspex
NVD
CVSS 3.1
7.5
EPSS
0.8%
CVE-2023-24965 Sep 08, 21:15 MEDIUM PATCH This Month

IBM Aspera Faspex 5.0.5 does not restrict or incorrectly restricts access to a resource from an unauthorized actor. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. This Exposure of Resource to Wrong Sphere vulnerability could allow attackers to access resources from an unintended security context.

Information Disclosure IBM Aspera Faspex
NVD
CVSS 3.1
5.3
EPSS
0.4%
CVE-2023-35906 Sep 05, 01:15 HIGH PATCH This Week

IBM Aspera Faspex 5.0.5 could allow a remote attacked to bypass IP restrictions due to improper access controls. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity.

Authentication Bypass IBM Aspera Faspex
NVD
CVSS 3.1
7.5
EPSS
0.3%
CVE-2023-22870 Sep 05, 01:15 MEDIUM PATCH This Month

IBM Aspera Faspex 5.0.5 transmits sensitive information in cleartext which could be obtained by an attacker using man in the middle techniques. Rated medium severity (CVSS 5.9), this vulnerability is remotely exploitable, no authentication required.

Information Disclosure IBM Aspera Faspex
NVD
CVSS 3.1
5.9
EPSS
0.3%
CVE-2023-27874 Mar 21, 15:15 HIGH PATCH This Week

IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. This XML External Entity (XXE) vulnerability could allow attackers to read arbitrary files or perform SSRF through XML processing.

IBM XXE Aspera Faspex
NVD
CVSS 3.1
8.8
EPSS
1.3%
CVE-2023-27873 Mar 21, 15:15 MEDIUM PATCH This Month

IBM Aspera Faspex 4.4.2 could allow a remote authenticated attacker to obtain sensitive credential information using specially crafted XML input. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, low attack complexity.

Information Disclosure IBM Aspera Faspex
NVD
CVSS 3.1
6.5
EPSS
0.8%
CVE-2023-27871 Mar 21, 15:15 HIGH PATCH This Week

IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user, using a specially crafted SQL query. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. This SQL Injection vulnerability could allow attackers to execute arbitrary SQL commands against the database.

SQLi IBM Aspera Faspex
NVD
CVSS 3.1
7.5
EPSS
0.9%
CVE-2023-27875 Mar 16, 13:15 HIGH PATCH This Week

IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity.

Authentication Bypass IBM Aspera Faspex
NVD
CVSS 3.1
7.5
EPSS
0.6%
CVE-2023-22868 Feb 17, 17:15 MEDIUM PATCH This Month

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. This Cross-Site Scripting (XSS) vulnerability could allow attackers to inject malicious scripts into web pages viewed by other users.

XSS IBM Aspera Faspex
NVD
CVSS 3.1
5.4
EPSS
0.4%
CVE-2022-22497 May 24, 22:15 HIGH PATCH This Week

IBM Aspera Faspex 4.4.1 and 5.0.0 could allow unauthorized access due to an incorrectly computed security token. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity.

Authentication Bypass IBM Aspera Faspex
NVD
CVSS 3.1
7.5
EPSS
1.1%
EPSS 0% CVSS 5.4
MEDIUM This Month

Aspera Faspex versions up to 5.0.14.3 contains a vulnerability that allows attackers to conduct various attacks against the vulnerable system, including cross-site scri (CVSS 5.4).

XSS IBM Aspera Faspex
NVD VulDB
EPSS 0% CVSS 5.4
MEDIUM This Month

IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. [CVSS 5.4 MEDIUM]

XSS IBM Aspera Faspex
NVD VulDB
EPSS 0% CVSS 5.4
MEDIUM This Month

HTML injection in IBM Aspera Faspex 5 (versions 5.0.0 through 5.0.14.1) allows an authenticated, low-privileged user to plant attacker-controlled HTML that is later rendered in a second victim's browser within the security context of the Faspex site. The triggering user must hold a valid Faspex account and must persuade or induce another user to view the affected content, and the impact stays confined to that victim's browsing session on the Faspex origin rather than the server itself. No public exploit code has been identified at time of analysis and there is no confirmed active exploitation (CISA KEV); with a CVSS 3.1 base score of 5.4, this is a moderate-severity, social-engineering-dependent issue rather than a mass-exploitation emergency.

XSS IBM Aspera Faspex
NVD VulDB
EPSS 0% CVSS 4.3
MEDIUM This Month

Authenticated users of IBM Aspera Faspex 5 (versions 5.0.0 through 5.0.14.1) can enumerate package identifiers to expose sensitive information about data packages they should not have visibility into. The flaw requires a valid low-privilege Faspex account and network access to the web application or API (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N, score 4.3), so it is not exploitable without credentials and impact is limited to confidentiality - no integrity or availability effect. With no public exploit identified at time of analysis and no confirmed active exploitation (not in CISA KEV), this is a low-to-moderate priority issue best addressed by upgrading and tightening package-level authorization, with risk scaling on multi-tenant instances that host many users' packages.

Information Disclosure IBM Aspera Faspex
NVD VulDB
EPSS 0% CVSS 3.8
LOW Monitor

Authenticated users of IBM Aspera Faspex 5 can access backend API features that are disabled in the web interface due to inconsistent permission enforcement (CWE-279), potentially leading to misuse of those features. Affected versions are 5.0.0 through 5.0.14.1. Exploitation requires a valid session and does not involve user interaction; impact is limited to low confidentiality and integrity effects, and no public exploit or active exploitation has been identified. This is assessed as a low-severity, low-priority access-control weakness.

Information Disclosure IBM Aspera Faspex
NVD VulDB
EPSS 0% CVSS 4.3
MEDIUM This Month

IBM Aspera Faspex versions 5.0.0 through 5.0.13.1 allow an authenticated low-privilege user to infer sensitive system information by observing discrepancies in returned data (CWE-203). The vulnerability requires valid credentials and only affects confidentiality with limited impact, as no data modification or service disruption is possible. No public exploit code has been identified, and the EPSS score is 0.23%, indicating a low likelihood of exploitation.

Information Disclosure IBM Aspera Faspex
NVD
EPSS 0% CVSS 4.9
MEDIUM This Month

Denial of service in IBM Aspera Faspex 5.0.0 through 5.0.13.1 allows a high-privileged, authenticated API user to consume excessive resources through improperly validated input, causing availability loss. Because exploitation requires PR:H credentials, realistic risk is confined to malicious insiders or post-compromise scenarios; EPSS is 0.32% (23rd percentile) and no public exploit has been identified at time of analysis.

Denial Of Service IBM Aspera Faspex
NVD
EPSS 0% CVSS 5.4
MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.12 is vulnerable to HTML injection. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

XSS IBM Aspera Faspex
NVD
EPSS 0% CVSS 7.1
HIGH This Week

IBM Aspera Faspex 5.0.0 through 5.0.12 could allow an authenticated user to obtain sensitive information or perform unauthorized actions on behalf of another user due to client-side enforcement of. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Information Disclosure IBM Aspera Faspex
NVD
EPSS 0% CVSS 7.1
HIGH This Week

IBM Aspera Faspex 5.0.0 through 5.0.12 could allow an authenticated user to obtain sensitive information or perform unauthorized actions on behalf of another user due to improper protection of. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Information Disclosure IBM Aspera Faspex
NVD
EPSS 0% CVSS 5.4
MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

XSS IBM Aspera Faspex
NVD
EPSS 0% CVSS 5.3
MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.10 could disclose sensitive username information due to an observable response discrepancy. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Information Disclosure IBM Aspera Faspex
NVD
EPSS 0% CVSS 4.4
MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.10 could allow a privileged user to make system changes without proper access controls. Rated medium severity (CVSS 4.4), this vulnerability is remotely exploitable. No vendor patch available.

Privilege Escalation IBM Aspera Faspex
NVD
EPSS 0% CVSS 5.9
MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.10 does not require that users should have strong passwords by default, which makes it easier for attackers to compromise user accounts. Rated medium severity (CVSS 5.9), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure IBM Brute Force +1
NVD
EPSS 0% CVSS 5.9
MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.10 does not require that users should have strong passwords by default, which makes it easier for attackers to compromise user accounts. Rated medium severity (CVSS 5.9), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure IBM Brute Force +1
NVD
EPSS 0% CVSS 8.1
HIGH This Week

IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user to bypass intended access restrictions and conduct resource modification. Rated high severity (CVSS 8.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass IBM Aspera Faspex
NVD
EPSS 0% CVSS 7.1
HIGH This Week

IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user to bypass intended access restrictions and conduct resource modification. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass IBM Aspera Faspex
NVD
EPSS 0% CVSS 6.5
MEDIUM This Month

IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user with access to the package to obtain sensitive information through a directory listing. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Information Disclosure IBM Aspera Faspex
NVD
EPSS 1% CVSS 7.5
HIGH PATCH This Week

IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist restrictions using a specially crafted HTTP request. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. This Incorrect Authorization vulnerability could allow attackers to bypass authorization checks to access restricted resources.

Authentication Bypass IBM Aspera Faspex
NVD
EPSS 0% CVSS 5.3
MEDIUM PATCH This Month

IBM Aspera Faspex 5.0.5 does not restrict or incorrectly restricts access to a resource from an unauthorized actor. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. This Exposure of Resource to Wrong Sphere vulnerability could allow attackers to access resources from an unintended security context.

Information Disclosure IBM Aspera Faspex
NVD
EPSS 0% CVSS 7.5
HIGH PATCH This Week

IBM Aspera Faspex 5.0.5 could allow a remote attacked to bypass IP restrictions due to improper access controls. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity.

Authentication Bypass IBM Aspera Faspex
NVD
EPSS 0% CVSS 5.9
MEDIUM PATCH This Month

IBM Aspera Faspex 5.0.5 transmits sensitive information in cleartext which could be obtained by an attacker using man in the middle techniques. Rated medium severity (CVSS 5.9), this vulnerability is remotely exploitable, no authentication required.

Information Disclosure IBM Aspera Faspex
NVD
EPSS 1% CVSS 8.8
HIGH PATCH This Week

IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. This XML External Entity (XXE) vulnerability could allow attackers to read arbitrary files or perform SSRF through XML processing.

IBM XXE Aspera Faspex
NVD
EPSS 1% CVSS 6.5
MEDIUM PATCH This Month

IBM Aspera Faspex 4.4.2 could allow a remote authenticated attacker to obtain sensitive credential information using specially crafted XML input. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, low attack complexity.

Information Disclosure IBM Aspera Faspex
NVD
EPSS 1% CVSS 7.5
HIGH PATCH This Week

IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user, using a specially crafted SQL query. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. This SQL Injection vulnerability could allow attackers to execute arbitrary SQL commands against the database.

SQLi IBM Aspera Faspex
NVD
EPSS 1% CVSS 7.5
HIGH PATCH This Week

IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity.

Authentication Bypass IBM Aspera Faspex
NVD
EPSS 0% CVSS 5.4
MEDIUM PATCH This Month

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. This Cross-Site Scripting (XSS) vulnerability could allow attackers to inject malicious scripts into web pages viewed by other users.

XSS IBM Aspera Faspex
NVD
EPSS 1% CVSS 7.5
HIGH PATCH This Week

IBM Aspera Faspex 4.4.1 and 5.0.0 could allow unauthorized access due to an incorrectly computed security token. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity.

Authentication Bypass IBM Aspera Faspex
NVD

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy